Human Induced Pluripotent Stem-Cardiac-Endothelial-Tumor-on-a-Chip to Assess Anticancer Efficacy and Cardiotoxicity

Cancer remains a leading health threat in the United States, and cardiovascular drug toxicity is a primary cause to eliminate a drug from FDA approval. As a result, the demand to develop new anticancer drugs without cardiovascular toxicity is high. Human induced pluripotent stem (iPS) cell-derived t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Tissue Eng Part C Methods
Autors principals: Weng, Kuo-Chan, Kurokawa, Yosuke K., Hajek, Brianna S., Paladin, Jack A., Shirure, Venktesh S., George, Steven C.
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc., publishers 2020
Matèries:
Methods Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6983745/
https://ncbi.nlm.nih.gov/pubmed/31797733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ten.tec.2019.0248
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars